July 2013 The Supreme Court and DNA Patents
The Supreme Court and DNA Patents: A Myriad of Ramifications
Monday, July 1, 2013
Wilson Sonsini Goodrich & Rosati
650 Page Mill Road
Palo Alto, CA 94304
Panel Discussion 3:30-5:30 PM
Networking Reception 5:30-7:00 PM
In Association for Molecular Pathology v Myriad Genetics, Inc., a unanimous Supreme Court held that isolated naturally-occurring human DNA is not patentable subject matter, but synthetic c-DNA is patent eligible. On July 1, The Berkeley Center for Law & Technology (BCLT) and the law firm of Wilson Sonsini Goodrich and Rosati will co-host a panel on the meaning and impact of the Court’s decision.
Benjamin Jackson, Senior Director of Legal Affairs at Myriad Genetics
Nathan Kelley, Deputy Solicitor at US Patent and Trademark Office
Vern Norviel, Wilson Sonsini Goodrich & Rosati
Michael Shuster, Fenwick & West LLP
Judge Alex Kozinski, United States Court of Appeals for the Ninth Circuit
The panel will be held at Wilson Sonsini Goodrich & Rosati's Palo Alto office at 3:30 PM and will be followed by a networking reception. Final logistics, including the exact location, will be sent before the event.
Please contact Associate Director Louise Lee at email@example.com to register.
2.0 hours of CLE credit will be available for this panel.